Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1995 1
1996 2
1997 1
1998 2
1999 3
2000 5
2001 2
2002 1
2009 2
2010 1
2011 1
2012 1
2013 2
2014 2
2015 3
2016 2
2017 1
2018 2
2020 1
2021 4
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean l carbon[Author] (76 results)?
Targeting androgen-independent pathways: new chances for patients with prostate cancer?
Cattrini C, Zanardi E, Vallome G, Cavo A, Cerbone L, Di Meglio A, Fabbroni C, Latocca MM, Rizzo F, Messina C, Rubagotti A, Barboro P, Boccardo F. Cattrini C, et al. Among authors: cerbone l. Crit Rev Oncol Hematol. 2017 Oct;118:42-53. doi: 10.1016/j.critrevonc.2017.08.009. Epub 2017 Aug 30. Crit Rev Oncol Hematol. 2017. PMID: 28917268 Review.
Defensive antibacterial coating in revision total hip arthroplasty: new concept and early experience.
Franceschini M, Sandiford NA, Cerbone V, Araujo LCT, Kendoff D. Franceschini M, et al. Among authors: cerbone v. Hip Int. 2020 Sep;30(1_suppl):7-11. doi: 10.1177/1120700020917125. Hip Int. 2020. PMID: 32907424
Defensive Antibacterial Coating (DAC), an antibacterial hydrogel coating made of hyaluronan, poly-D and L-lactide can protect biomaterials as an effective barrier at the time of implantation. ...
Defensive Antibacterial Coating (DAC), an antibacterial hydrogel coating made of hyaluronan, poly-D and L-lactide can protect biomate …
New medical approaches in pituitary adenomas.
Colao A, Di Sarno A, Marzullo P, Di Somma C, Cerbone G, Landi ML, Faggiano A, Merola B, Lombardi G. Colao A, et al. Among authors: cerbone g. Horm Res. 2000;53 Suppl 3:76-87. doi: 10.1159/000023539. Horm Res. 2000. PMID: 10971110 Review.
In acromegaly, disease control (growth hormone [GH] <2.5-1.0 microg/l as a fasting or glucose-suppressed value, respectively, together with age-normalised insulin-like growth factor [IGF]-I) is achievable in more than half of patients receiving treatment with lanreotide …
In acromegaly, disease control (growth hormone [GH] <2.5-1.0 microg/l as a fasting or glucose-suppressed value, respectively, toge …
Sexual Dysfunction in Patients With Chronic Gastrointestinal and Liver Diseases: A neglected Issue.
Romano L, Granata L, Fusco F, Napolitano L, Cerbone R, Priadko K, Sciorio C, Mirone V, Romano M. Romano L, et al. Among authors: cerbone r. Sex Med Rev. 2022 Oct;10(4):620-631. doi: 10.1016/j.sxmr.2021.02.002. Epub 2021 Aug 3. Sex Med Rev. 2022. PMID: 34353738 Review.
CONCLUSION: Based on this review, a thorough evaluation of sexual function through validated questionnaires and/or psychological interviews with patients with chronic gastrointestinal disorders should be part of the clinical assessment in order to timely diagnose and possibly tre …
CONCLUSION: Based on this review, a thorough evaluation of sexual function through validated questionnaires and/or psychological interviews …
Frontline immune checkpoint inhibitor-based combination therapy in metastatic renal cell carcinoma patients with poor performance status.
Carril-Ajuria L, Colomba E, Romero-Ferreiro C, Cerbone L, Ratta R, Barthelemy P, Vindry C, Fléchon A, Cherifi F, Boughalem E, Linassier C, Fornarini G, Rebuzzi SE, Gross-Goupil M, Saldana C, Martin-Soberón M, de Velasco G, Manneh R, Pernaut C, Sanchez de Torre A, Flippot R, Escudier B, Albiges L. Carril-Ajuria L, et al. Among authors: cerbone l. Eur J Cancer. 2023 Feb;180:21-29. doi: 10.1016/j.ejca.2022.11.013. Epub 2022 Nov 26. Eur J Cancer. 2023. PMID: 36527973
Circulating acetylated polyamines correlate with Covid-19 severity in cancer patients.
Bourgin M, Derosa L, Silva CAC, Goubet AG, Dubuisson A, Danlos FX, Grajeda-Iglesias C, Cerbone L, Geraud A, Laparra A, Aprahamian F, Nirmalathasan N, Madeo F, Zitvogel L, Kroemer G, Durand S. Bourgin M, et al. Among authors: cerbone l. Aging (Albany NY). 2021 Sep 13;13(17):20860-20885. doi: 10.18632/aging.203525. Epub 2021 Sep 13. Aging (Albany NY). 2021. PMID: 34517343 Free PMC article.
Response to systemic therapy in fumarate hydratase-deficient renal cell carcinoma.
Carril-Ajuria L, Colomba E, Cerbone L, Romero-Ferreiro C, Crouzet L, Laguerre B, Thibault C, Vicier C, de Velasco G, Fléchon A, Saldana C, Benusiglio PR, Bressac-de Paillerets B, Guillaud-Bataille M, Gaignard P, Scoazec JY, Richard S, Caron O, Escudier B, Albiges L. Carril-Ajuria L, et al. Among authors: cerbone l. Eur J Cancer. 2021 Jul;151:106-114. doi: 10.1016/j.ejca.2021.04.009. Epub 2021 May 8. Eur J Cancer. 2021. PMID: 33975058
Effects of L-thyroxine treatment on early markers of atherosclerotic disease in children with subclinical hypothyroidism.
Cerbone M, Capalbo D, Wasniewska M, Alfano S, Mattace Raso G, Oliviero U, Cittadini A, De Luca F, Salerno M. Cerbone M, et al. Eur J Endocrinol. 2016 Jul;175(1):11-9. doi: 10.1530/EJE-15-0833. Epub 2016 Apr 11. Eur J Endocrinol. 2016. PMID: 27068687
OBJECTIVE: To investigate the effect of levothyroxine (L-T4) treatment on early markers of atherosclerotic disease in children with mild idiopathic subclinical hypothyroidism (SH). ...ADMA concentrations at baseline were higher in SH subjects compared with controls (0.770. …
OBJECTIVE: To investigate the effect of levothyroxine (L-T4) treatment on early markers of atherosclerotic disease in children with m …
Application of the Meet-URO score to metastatic renal cell carcinoma patients treated with second- and third-line cabozantinib.
Rebuzzi SE, Cerbone L, Signori A, Santoni M, Murianni V, De Giorgi U, Procopio G, Porta C, Milella M, Basso U, Massari F, Maruzzo M, Iacovelli R, Battelli N, Carmisciano L, Banna GL, Buti S, Fornarini G. Rebuzzi SE, et al. Among authors: cerbone l. Ther Adv Med Oncol. 2022 Feb 26;14:17588359221079580. doi: 10.1177/17588359221079580. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35237353 Free PMC article.
43 results